Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

CAR-T cell therapy research

52 ta ish

  1. ALL-311: Results of Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL) in Children in Uzbekistan

    Indira Erimbetova, Sapura Ibragimova

    MaqolaCAR-T cell therapy researchClinical Lymphoma Myeloma & Leukemia20250 iqtibos
    ABI

  2. POSTER: ALL-311 Results of Treatment of T-Cell Acute Lymphoblastic Leukemia (T-ALL) in Children in Uzbekistan

    Indira Erimbetova, Sandugash Ibragimova

    MaqolaCAR-T cell therapy researchClinical Lymphoma Myeloma & Leukemia20250 iqtibos
    ABI

  3. Immuno-oncology approaches to overcome T cell exhaustion in melanoma

    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohammad Y. Alshahrani, Muzdalifa Mejbel Fedwi +7

    MaqolaCancer Immunotherapy and BiomarkersSeminars in Oncology20250 iqtibos
    ABI

  4. CAR-T HUJAYRA TERAPIYASINING BOLALAR VA YOSH KATTALARDAGI OʻTKIR LIMFOBLASTIK LEYKEMIYADA TIMUSNING MORFOLOGIK VA MORFOMETRIK XUSUSIYATLARIGA TA'SIRI: SISTEMATIK TAHLIL VA META-TAHLIL

    Ruzieva Maftuna Bahtiyor qizi, Allaberganov Dilshod Shavkatovich

    MaqolaCAR-T cell therapy researchZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  5. CAR-T HUJAYRA TERAPIYASINING BOLALAR VA YOSH KATTALARDAGI OʻTKIR LIMFOBLASTIK LEYKEMIYADA TIMUSNING MORFOLOGIK VA MORFOMETRIK XUSUSIYATLARIGA TA'SIRI: SISTEMATIK TAHLIL VA META-TAHLIL

    Ruzieva Maftuna Bahtiyor qizi, Allaberganov Dilshod Shavkatovich

    MaqolaCAR-T cell therapy researchZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  6. RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR

    Xoliqberdiyeva Zebo Rasuljon qizi

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  7. RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR

    Xoliqberdiyeva Zebo Rasuljon qizi

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  8. RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR

    Kudratova Nozanin

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  9. RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR

    Kudratova Nozanin

    MaqolaImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  10. Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers

    Minzhi Huang, Ahmad Ewadi, Nazli Servatian +6

    Sharh maqolaCRISPR and Genetic EngineeringCritical Reviews in Oncology/Hematology20250 iqtibos
    ABI

  11. The multifaceted role of CS1 (SLAMF7) in immunoregulation: Implications for cancer therapy and autoimmune disorders

    Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya +7

    Sharh maqolaImmune Cell Function and InteractionExperimental Cell Research20250 iqtibos
    ABI

  12. New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK

    Saade Abdalkareem Jasim, Harikumar Pallathadka, G. V. Sivaprasad +7

    Sharh maqolaCAR-T cell therapy researchFunctional & Integrative Genomics20250 iqtibos
    ABI

  13. Next-generation CAR-T and CAR-NK cell therapies in hematologic malignancies: engineering for persistence, specificity, and safety

    Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    MaqolaCAR-T cell therapy researchDiscover Oncology20260 iqtibos
    ABI

  14. Bispecific and multispecific immune engagers for redirecting innate and adaptive immunity against hematologic cancers

    Mustafa T. Ardah, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

    MaqolaMonoclonal and Polyclonal Antibodies ResearchDiscover Oncology20260 iqtibos
    ABI

  15. Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers

    Ghaleb Oriquat, Waleed K. Abdulsahib, Sajida Hussein Ismael +6

    MaqolaImmune Cell Function and InteractionAnnals of Hematology20260 iqtibos
    ABI

  16. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer

    Viktoria B. Poluektova, Svetlana N. Zuevskaya, Yarmatov Suvon +3

    MaqolaCAR-T cell therapy researchClinical & Translational Oncology20260 iqtibos
    ABI

  17. CAR‐NK Cell Biology and Engineering for Solid Tumors, With a Focus on Lung Cancer

    Xiao Lyu, Na Zhu, Ruijuan Guo +1

    MaqolaCAR-T cell therapy researchCell Biology International20260 iqtibos
    ABI

  18. PERSONALIZED MEDICINE AND GENE THERAPY: REVOLUTIONIZING HEALTHCARE THROUGH PRECISION INTERVENTIONS

    Dr. Saloni Jain, Humaira Abdullah, Madiha Rahmani +1

    MaqolaCRISPR and Genetic EngineeringZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  19. PERSONALIZED MEDICINE AND GENE THERAPY: REVOLUTIONIZING HEALTHCARE THROUGH PRECISION INTERVENTIONS

    Dr. Saloni Jain, Humaira Abdullah, Madiha Rahmani +1

    MaqolaCRISPR and Genetic EngineeringZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  20. Antibody therapies in glioblastoma: Overcoming micro-environmental barriers.

    Moeen F. Dababneh, Faris Anad Muhammad, Abdulkareem Shareef +10

    MaqolaGlioma Diagnosis and TreatmentPubMed20260 iqtibos
    ABI

  21. Advances in monitoring and therapy from minimal residual disease to CAR-T cells in multiple myeloma and precursor disorders

    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Ghaleb Oriquat, Sokhib Saidov +5

    MaqolaCAR-T cell therapy researchClinica Chimica Acta20260 iqtibos
    ABI

  22. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

    E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

    MaqolaPluripotent Stem Cells ResearchClinical & Translational Oncology20260 iqtibos
    ABI

  23. Prognostic significance of CD8+T lymphocytes and CD68+ macrophages in assessing pathologic response in pediatric soft tissue sarcomas.

    D. Polatova, Nargiza Karimova

    MaqolaSarcoma Diagnosis and TreatmentJournal of Clinical Oncology20260 iqtibos
    ABI

  24. Comment on “Daratumumab, lenalidomide, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma: A real-world propensity score-matched study”

    Shobana Chandrasekar, M.K. Rohith Krishnan, Umesh Kumar

    MaqolaMultiple Myeloma Research and TreatmentsJournal of the Formosan Medical Association20260 iqtibos
    ABI

  25. A COMPREHENSIVE ANALYSIS OF CURRENT APPROACHES TO THE DIAGNOSIS AND THERAPY OF LEUKEMIAS, LYMPHOMAS, AND MULTIPLE MYELOMA

    Komil Eshkuvatov, Charos Kahramonova, Umida Musayeva

    MaqolaDigital Imaging for Blood DiseasesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI